← Back to catalogue

Certolizumab CLIA kit (Chemiluminescence Immunoassay)

EUDAMED

Class B (EU MDR)

Ref F11471Model 100 tests/box

by Beijing Diagreat Biotechnologies Co., Ltd.

Identity

Trade Name
Certolizumab CLIA kit (Chemiluminescence Immunoassay) EUDAMED
Device Name
Certolizumab CLIA kit (Chemiluminescence Immunoassay) EUDAMED
Model / Reference
100 tests/box EUDAMED
F11471 EUDAMED

Identifiers

Primary DI / UDI-DI
06942293552337 EUDAMED
Basic UDI-DI
697518250F114712K EUDAMED
Direct Marketing DI
06942293552337 EUDAMED
EMDN Code
W0102080799 AUTOIMMUNE DISEASE TDM - OTHER EUDAMED

Classification

Device Class
Class B EUDAMED
Market of Registration
Italy EUDAMED

Clinical & Handling

Sterile

No

EUDAMED

Human Tissues

No

EUDAMED

Animal Tissues

No

EUDAMED

Microbial Substances

No

EUDAMED

Reagent

Yes

EUDAMED

Self Testing

No

EUDAMED

Near-Patient Testing

No

EUDAMED

Professional Testing

Yes

EUDAMED

Companion Diagnostics

No

EUDAMED

Surgical Instrument

No

EUDAMED

New Device

Yes

EUDAMED

The Certolizumab CLIA kit (Chemiluminescence Immunoassay) is a highly accurate and reliable diagnostic tool used in medical settings to monitor patients' responses to treatment for certain autoimmune diseases. This device has undergone rigorous testing and has been certified by regulatory bodies, ensuring its safety and efficacy.

Authorization Coverage (European Union — 27 member states)

Regulatory Authorizations

European Union Active

CE/IVDR

Is this your device? Claim it to add documentation and request validation.

Manufacturer

EUDAMED SRN
CN-MF-000019511
Authorised Representative
Medunion S.L. ES-AR-000019366

Sources (1)

  • EUDAMED 20e3d170-87b0-4ade-9cf5-760849307f57 61 fields · synced Jun 25, 2026